D
Bio-Rad Laboratories, Inc. BIO
$285.95 -$4.43-1.53% NYSE
Recommendation
Prev Close
$290.38
Volume
231,851
Avg Vol (90D)
332,107
Market Cap
$7.64B
Dividend & Yield
--
52-Week Range
$211.43 - $387.99
P/E (TTM)
24.75
EPS (TTM)
$11.73
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Bio-Rad Laboratories, Inc. $BIO Stock Position Lessened by Select Equity Group L.P.
9/9/2025 - MarketBeat
Petrus Trust Company LTA Grows Position in Bio-Rad Laboratories, Inc. $BIO
9/8/2025 - MarketBeat
Bio-Rad Laboratories, Inc. (BIO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
9/4/2025 - Seeking Alpha: Transcripts
Bio-Rad Laboratories, Inc. (BIO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
9/4/2025 - SeekingAlpha
America's billionaires are older than ever, with one in five already in their 80s or 90s as millennials await the Great Wealth Transfer
9/4/2025 - Fortune
Bio-Rad Laboratories (BIO, $290.71) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 2, 2025
9/3/2025 - Tickeron - Technical Analysis
Bio-Rad Laboratories (BIO) Gets a Buy from RBC Capital
9/2/2025 - TipRanks Financial Blog
Is Bio-Rad Laboratories (BIO) Entering a Period of More Sustained Recovery?
9/2/2025 - Insider Monkey
Is Bio-Rad Laboratories (BIO) Entering a Period of More Sustained Recovery?
9/2/2025 - Yahoo! Finance: News
How Investors May Respond To Bio-Rad Laboratories (BIO) Launching StarBright Dyes for Flow Cytometry
9/2/2025 - Simply Wall St
Comerica Bank Sells 44,121 Shares of Bio-Rad Laboratories, Inc. $BIO
9/2/2025 - MarketBeat
Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now?
9/1/2025 - Zacks Investment Research
Parnassus Investments LLC Grows Stock Position in Bio-Rad Laboratories, Inc. $BIO
8/31/2025 - MarketBeat
Earnest Partners LLC Sells 18,428 Shares of Bio-Rad Laboratories, Inc. $BIO
8/29/2025 - MarketBeat
Bio-Rad Laboratories (NYSE:BIO) Rating Increased to Hold at Zacks Research
8/28/2025 - Ticker Report
Bio-Rad Laboratories (BIO) Gets a Buy from UBS
8/27/2025 - TipRanks Financial Blog
BI Asset Management Fondsmaeglerselskab A S Sells 980 Shares of Bio-Rad Laboratories, Inc. $BIO
8/27/2025 - MarketBeat
Bio-Rad's Management to Participate in Upcoming Investor Conferences
8/25/2025 - GuruFocus
Bio-Rad's Management to Participate in Upcoming Investor Conferences
8/25/2025 - Business Wire
Candriam S.C.A. Sells 20,243 Shares of Bio-Rad Laboratories, Inc. $BIO
8/25/2025 - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Stock Crosses Above 50-Day Moving Average - Here's What Happened
8/24/2025 - MarketBeat
Bio-Rad Laboratories (BIO): Evaluating Valuation Following EZ-Check Salmonella Kit Launch and Major Industry Certifications
8/23/2025 - Simply Wall St
Quantbot Technologies LP Acquires New Shares in Bio-Rad Laboratories, Inc. $BIO
8/23/2025 - MarketBeat
Bio-Rad Laboratories (BIO, $303.82) price may drop as it broke higher Bollinger Band on Aug 22, 2025
8/23/2025 - Tickeron - Stocks
Bio-Rad Laboratories (BIO, $303.82) RSI Indicator left the overbought zone on August 22, 2025
8/23/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$2.55B
EBITDA (TTM)
$415.60M
EBIT (TTM)
$258.80M
Net Income (TTM)
$319.17M
Balance Sheet
Total Assets (Q)
$10.21B
Total Debt (Q)
$1.41B
Total Liabilities (Q)
$3.09B
Book Value Per Share (Q)
$263.42
Cash Flow
Cash from Operations (TTM)
$534.16M
Cash from Investing (TTM)
-$198.68M
Cash from Financing (TTM)
-$356.23M
Net Change in Cash (TTM)
-$36.05M
Filings
Filing Date
Thursday, July 31, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Oct 27 and 31 (est)
Price History
Loading...
Beta
0.82
7-Day Total Return
-2.63%
30-Day Total Return
12.92%
60-Day Total Return
23.03%
90-Day Total Return
17.15%
Year to Date Total Return
-12.33%
1-Year Total Return
-11.50%
2-Year Total Return
-21.16%
3-Year Total Return
-43.86%
5-Year Total Return
-42.98%
52-week Low
Jun 03, 2025 - $211.43
52-week High
Nov 06, 2024 - $387.99
Valuation
Market Cap
$7.64B - Mid Cap
Enterprise Value
$7.67B
Price/Sales (TTM)
3.10
Price/Book (Q)
1.10
Dividends and Shares
Shares Outstanding
27.23
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.bio-rad.com
Phone Number
510 724 7000
Address
1000 Alfred Nobel Drive
Hercules, CA 94547
Country
United States
Year Founded
1952
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through... more
NYSE 09/09/2025 4:00PM Eastern Quotes delayed